Stocktoria60 DEGREES PHARMACEUTICALS, INC. SXTP
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $1.0M | $607,574 | $253,573 | $223,208 |
| Gross profit | $223,776 | $222,809 | -$220,977 | -$209,162 |
| Operating income | -$7.8M | -$9.7M | -$5.2M | -$1.8M |
| Net income | -$7.4M | -$7.9M | -$3.8M | -$6.2M |
| Operating cash flow | -$6.8M | -$5.6M | -$4.5M | -$1.0M |
| Free cash flow | -$7.0M | -$5.8M | -$4.6M | — |
| Total assets | $5.4M | $5.8M | $7.8M | $1.3M |
| Total liabilities | $2.0M | $1.8M | $3.0M | $25.4M |
| Shareholders' equity | $3.4M | $4.0M | $4.8M | -$24.1M |
| Ratios | ||||
| Gross margin | 22.3% | 36.7% | -87.1% | -93.7% |
| Operating margin | -771.6% | -1599.0% | -2032.8% | -784.2% |
| Net margin | -732.5% | -1308.0% | -1485.1% | -2769.5% |
| FCF margin | -695.1% | -946.7% | -1814.3% | — |
| Return on assets | -137.3% | -138.0% | -48.4% | -476.5% |
| Return on equity | -217.9% | -200.9% | -78.5% | 25.6% |
| Debt / equity | 0.04× | 0.04× | 0.03× | -0.70× |
| Current ratio | 2.66 | 3.25 | 2.55 | 0.05 |
| Revenue growth | 65.5% | 139.6% | 13.6% | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001946563 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.